G1 Therapeutics, Inc.
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
Insights
Strategic Partnerships G1 Therapeutics has actively formed collaborations with pharmaceutical and biotech companies such as Pharmacosmos and Pepper Bio, indicating openness to joint ventures and licensing deals that could be explored for technology integration, co-development, or distribution opportunities.
Product Launch Expansion The recent launch of COSELA for small cell lung cancer therapeutics demonstrates the company's growing portfolio in oncology. This expansion signals potential demand for complementary products, services, or support solutions tailored to their oncology pipeline.
Funding & Growth With significant funding of over $461 million and a successful public offering, G1 Therapeutics is positioned for accelerated growth and investment in innovative research, creating opportunities to engage with their expanding research and development initiatives.
Focus on Oncology As a commercial-stage oncology company, G1 Therapeutics is targeting a high-growth healthcare sector, making it a valuable partner for suppliers of oncology-focused technology, clinical development tools, and patient management solutions.
Technological Infrastructure Utilizing a range of advanced digital tools and compliance platforms like Akamai, OneTrust, and Adobe Tag Manager, the company emphasizes modern digital operations, which can open doors for sales in cybersecurity, digital marketing, and regulatory compliance solutions tailored for biotech firms.
G1 Therapeutics, Inc. Tech Stack
G1 Therapeutics, Inc. uses 8 technology products and services including Akamai, Drupal, OneTrust, and more. Explore G1 Therapeutics, Inc.'s tech stack below.
- AkamaiContent Delivery Network
- DrupalContent Management System
- OneTrustCookie Compliance
- Microsoft ExcelEditors
- ModernizrJavascript Libraries
- DocuSignMiscellaneous
- Adobe Tag ManagerTag Management
- DreamHostWeb Hosting
Media & News
G1 Therapeutics, Inc.'s Email Address Formats
G1 Therapeutics, Inc. uses at least 1 format(s):
| G1 Therapeutics, Inc. Email Formats | Percentage |
| FLast@g1therapeutics.com | 93% |
| FirstLast@g1therapeutics.com | 5% |
| First.Last@g1therapeutics.com | 1% |
| FirLast@g1therapeutics.com | 1% |
Frequently Asked Questions
Where is G1 Therapeutics, Inc.'s headquarters located?
G1 Therapeutics, Inc.'s main headquarters is located at 700 Park Offices Drive Suite 200 Durham, North Carolina 27709 United States. The company has employees across 4 continents, including North AmericaAsiaEurope. What is G1 Therapeutics, Inc.'s phone number?
You can contact G1 Therapeutics, Inc.'s main corporate office by phone at +1-919-966-****
What is G1 Therapeutics, Inc.'s stock symbol?
G1 Therapeutics, Inc. is a publicly traded company; the company's stock symbol is GTHX. What is G1 Therapeutics, Inc.'s official website and social media links?
G1 Therapeutics, Inc.'s official website is g1therapeutics.com and has social profiles on LinkedInCrunchbase.What is G1 Therapeutics, Inc.'s SIC code NAICS code?
G1 Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does G1 Therapeutics, Inc. have currently?
As of February 2026, G1 Therapeutics, Inc. has approximately 51 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer, Senior Vice President Corporate Development: B. P.Chief Business Officer And Secretary: G. M.Vice President Head Of Medical Affairs: M. C.. Explore G1 Therapeutics, Inc.'s employee directory with LeadIQ.What industry does G1 Therapeutics, Inc. belong to?
G1 Therapeutics, Inc. operates in the Biotechnology Research industry. What technology does G1 Therapeutics, Inc. use?
G1 Therapeutics, Inc.'s tech stack includes AkamaiDrupalOneTrustMicrosoft ExcelModernizrDocuSignAdobe Tag ManagerDreamHost. What is G1 Therapeutics, Inc.'s email format?
G1 Therapeutics, Inc.'s email format typically follows the pattern of FLast@g1therapeutics.com. Find more G1 Therapeutics, Inc. email formats with LeadIQ. How much funding has G1 Therapeutics, Inc. raised to date?
As of February 2026, G1 Therapeutics, Inc. has raised $461M in funding. The last funding round occurred on Feb 22, 2019 for $5M.When was G1 Therapeutics, Inc. founded?
G1 Therapeutics, Inc. was founded in 2008.
Company Overview
- Headquarters
- 700 Park Offices Drive Suite 200 Durham, North Carolina 27709 United States
- Phone number
- +1-919-966-****
- Website
- g1therapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- GTHX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2008
- Employees
- 51-200
Media & News
Funding & Financials
- $461M
G1 Therapeutics, Inc. has raised a total of $461M of funding over 5 rounds. Their latest funding round was raised on Feb 22, 2019 in the amount of $5M.
- $1M$10M
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $461M
G1 Therapeutics, Inc. has raised a total of $461M of funding over 5 rounds. Their latest funding round was raised on Feb 22, 2019 in the amount of $5M.
- $1M$10M
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
Company Leadership
B. P.Chief Financial Officer, Senior Vice President Corporate Development
G. M.Chief Business Officer And Secretary- M. C.Vice President Head Of Medical Affairs
- H. K.Vp, Commercial Counsel
J. Z.Senior Director, Biostatistics
Employee Directory
- B. Q.Lifesciences R&d Director
- C. S.Independent Board Director
- D. W.Senior Director, Clinical Scientist
- J. H. M.Associate Director, Product Development Outsourcing
- J. R.Director, Statistical Programming
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
